drugset / Trial / NCT04143412

Efficacy of ACE Inhibitors, MRAs and ACE Inhibitor/ MRA Combination

NCT04143412

Phase 2 Unknown 75 enrolled Beni-Suef University
RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of our work is to compare the antiproteinuric efficacy of ACEI monotherapy, Selective MRA monotherapy and their combination in mildly hypertensive patients with type 2 diabetes mellitus and microalbuminuria

Timeline

Start
2019-02-04
Primary completion
2020-02
Completion
2020-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Eplerenone Unknown 50 mg
Comparator Ramipril Small molecule 10 mg